Summary
It has been suggested that fragile sites on human chromosomes predispose to specific rearrangements seen in cancer. Renal cell carcinoma is characterised by recurrent aberrations of chromosome 3p and frequent rearrangements of chromosome 5q. To investigate whether there might be an association between fragile sites and recurrent breakpoints in renal cell carcinoma, we have determined the breakpoints observed in 50 tumours and compared them to the known fragile sites on chromosomes 3 and 5. No correlation between fragile sites and cancer-related breakpoints in renal cell carcinomas was found.
This is a preview of subscription content, log in via an institution to check access.
References
Berger CS, Sandberg AA, Todd IAD, Pennington RD, Haddad FS, Hecht BK, Hecht F (1986) Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet Cytogenet 23:1–24
Bonner T, O'Brien SJ, Nash WG, Rapp UR (1984) The human homologs of the raf (mil) oncogene are located on human chromosomes 3 and 4. Science 223:71–74
Carroll PR, Murty VVS, Reuter V, Jhanwar S, Fair WR, Whitmore WF, Chaganti RSK (1987) Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet 26:253–259
Cavenee WK, Koufos A, Hansen MF (1986) Recessive mutant genes predisposing to human cancer. Mutat Res 168:3–14
Drabkin H, Kao FT, Weinberger C, Evans R (1987) Human c-erb-A is located at chromosome 3p21.33-p22. 3rd Annual Meeting on Oncogenes, Fredericd, Md (abstr)
Heim S, Mitelman F (1987a) Myelodysplastic syndromes. In: Heim S, Mitelman F (eds) Cancer cytogenetics. Liss, New York, pp 111–128
Heim S, Mitelman F (1987b) Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 bands involved in primary cancer-specific rearrangements. Hum Genet 75:70–72
Human Gene Mapping 8 (1985) (8th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 40 nos 1–4
ISCN (1985) An international system for human cytogenetic nomenclature. Karger, Basel
Klein G, Klein E (1985) Evolution of tumours and the impact of molecular oncology. Nature 315:190–195
Kovacs G, Szücs S, DeRiese W, Baumgärtel H (1987) Specific chromosome aberration in human renal cell carcinoma. Int J Cancer 40:171–178
Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, Sümegi J (1988) Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85:1571–1575
LeBeau M (1986) Chromosomal fragile sites and cancer-specific rearrangements. Blood 67:849–858
LeBeau M, Westbrook CA, Diaz MO, Larson RA, Rowley JD, Gasson JC, Golde DW, Sherr CJ (1986) Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science 231:984–987
Mitelman F (1986) Clustering of breakpoints to specific chromosomal regions in human neoplasia. A survey of 5,345 cases. Hereditas 104:113–119
Simmers RN, Sutherland GR, West A, Richards RI (1987) Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangement in AMMoL. Science 236:92–94
Yoshida MA, Ohyashiki K, Ochi H, Gibas Z, Pontes JE, Prout GR, Sandberg AA (1986) Cytogenetic studies of tumor tissue from patients with non-familial renal cell carcinoma. Cancer Res 46:2139–2147
Yunis JJ, Soreng AL, Bowe AE (1987) Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1:59–69
Zbar B, Brauch H, Talmadge C, Linehan M (1987) Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721–724
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kovacs, G., Brusa, P. Recurrent genomic rearrangements are not at the fragile sites on chromosomes 3 and 5 in human renal cell carcinomas. Hum Genet 80, 99–101 (1988). https://doi.org/10.1007/BF00451467
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00451467